ArticleOncology and therapy2025

Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations.

Vânia Hungria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.